News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
586,172 Results
Type
Article (20830)
Company Profile (333)
Press Release (565005)
Multimedia
Podcasts (123)
Webinars (16)
Section
Business (194356)
Career Advice (435)
Deals (29893)
Drug Delivery (67)
Drug Development (71314)
Employer Resources (40)
FDA (12264)
Job Trends (10565)
News (285132)
Policy (22151)
Tag
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (2)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (12)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (7)
2027 Genetown Digital (3)
2027 Genetown Elite (3)
2027 Genetown Standard (9)
2027 NextGen (8)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (8)
40 Under 40 (1)
Academia (1248)
Accelerated approval (48)
ADA (38)
Adcomms (16)
Allergies (155)
Alliances (41155)
ALS (233)
Alzheimer's disease (1528)
Antibody-drug conjugate (ADC) (616)
Approvals (12953)
Artificial intelligence (650)
ASCO (272)
Autoimmune disease (410)
Automation (41)
Bankruptcy (302)
Belgium (19)
Best Places to Work (8500)
BIO (65)
Biologics (40)
BIOSECURE Act (6)
Biosimilars (195)
BioSpace Insights (90)
Biotechnology (228)
Bispecific (21)
Bladder cancer (182)
Brain cancer (73)
Breast cancer (727)
Cancer (6009)
Cardiovascular disease (439)
Career advice (382)
Career pathing (15)
CAR-T (355)
CDC (9)
CDMO (126)
Celiac Disease (4)
Cell therapy (957)
Cervical cancer (45)
Clinical research (64151)
Collaboration (2196)
Commercialization (32)
Company closure (4)
Compensation (1705)
Complete response letters (78)
COVID-19 (1456)
CRISPR (132)
CRO (1)
C-suite (1307)
Cystic fibrosis (151)
Data (8751)
Denatured (28)
Depression (171)
Dermatology (146)
Diabetes (546)
Diagnostics (4913)
Digital health (47)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (384)
Drug pricing (60)
Drug shortages (6)
Duchenne muscular dystrophy (346)
Earnings (80833)
Editorial (38)
Employer branding (6)
Employer resources (38)
Events (104392)
Executive appointments (1045)
Eye disease (10)
FDA (16133)
Fibrodysplasia Ossificans Progressiva (14)
Fragile X (3)
Friedreich's ataxia (26)
Frontotemporal dementia (38)
Funding (1791)
Gene editing (273)
Generative AI (51)
Gene therapy (776)
GLP-1 (722)
Government (1770)
Grass and pollen (4)
Guidances (336)
Healthcare (12078)
Hematology (150)
HIV (74)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (118)
Immunology and inflammation (306)
Immuno-oncology (120)
Indications (233)
Infectious disease (1732)
Inflammatory bowel disease (223)
Inflation Reduction Act (12)
Influenza (98)
Intellectual property (329)
Interviews (58)
IPO (14385)
IRA (13)
Job creations (2423)
Job search strategy (340)
JPM (41)
Kidney cancer (22)
Kidney disease (104)
Labor market (42)
Layoffs (313)
Leadership (21)
Legal (5649)
Licensing (67)
Liver cancer (69)
Longevity (41)
Lung cancer (849)
Lung diease (15)
Lymphoma (424)
Machine learning (49)
Management (10)
Manufacturing (962)
Marketing (21)
MASH (196)
Medical affairs (3)
Medical device (9968)
Medtech (10164)
Mergers & acquisitions (16790)
Metabolic disorders (1335)
mRNA (222)
Multiple sclerosis (170)
Multispecific (5)
NASH (14)
Netherlands (11)
Neurodegenerative disease (474)
Neuropsychiatric disorders (109)
Neuroscience (3184)
Neurotech (2)
NextGen: Class of 2026 (4128)
Non-profit (1520)
Now hiring (47)
Obesity (560)
Opinion (161)
Ovarian cancer (245)
Pain (252)
Pancreatic cancer (357)
Parkinson's disease (400)
Partnered (26)
Patents (647)
Patient advocacy (4)
Patient recruitment (840)
Patient selection (55)
Peanut (58)
People (49940)
Peptides (19)
Pharmaceutical (50)
Pharmacy benefit managers (15)
Phase 1 (21178)
Phase 2 (28947)
Phase 3 (19692)
Pipeline (10985)
Policy (118)
Postmarket research (1891)
Preclinical (9032)
Press Release (52)
Prostate cancer (311)
Psychedelics (84)
Radioligand (2)
Radiopharmaceuticals (376)
Rare diseases (1210)
Real estate (3780)
Recruiting (14)
Regenerative medicine (17)
Regulatory (19915)
Reports (36)
Research institute (1338)
Resumes & cover letters (59)
Rett syndrome (53)
RNA editing (35)
RSV (58)
Schizophrenia (185)
Series A (335)
Series B (232)
Service/supplier (5)
Sickle cell disease (121)
Special edition (23)
Spinal muscular atrophy (148)
Sponsored (25)
Startups (3129)
State (1)
Stem cells (4)
Stomach cancer (8)
Substance use disorders (20)
Supply chain (79)
Tariffs (20)
The Weekly (93)
Vaccines (607)
Venture capital (116)
Weight loss (283)
Wet AMD (5)
Women's health (123)
Worklife (3)
Date
Today (142)
Last 7 days (582)
Last 30 days (2167)
Last 365 days (26140)
2026 (20737)
2025 (25757)
2024 (30028)
2023 (33976)
2022 (43313)
2021 (45731)
2020 (40883)
2019 (29829)
2018 (22460)
2017 (24179)
2016 (22653)
2015 (28865)
2014 (24869)
2013 (20673)
2012 (22487)
2011 (22746)
2010 (22422)
Location
Africa (341)
Alabama (100)
Alaska (3)
Arizona (360)
Arkansas (15)
Asia (29229)
Australia (4497)
California (14674)
Canada (3970)
China (1463)
Colorado (607)
Connecticut (573)
Delaware (395)
Europe (54435)
Florida (2155)
Georgia (443)
Hawaii (4)
Idaho (47)
Illinois (1017)
India (98)
Indiana (467)
Iowa (22)
Japan (605)
Kansas (119)
Kentucky (41)
Louisiana (43)
Maine (38)
Maryland (1535)
Massachusetts (10575)
Michigan (336)
Minnesota (665)
Mississippi (5)
Missouri (98)
Montana (32)
Nebraska (14)
Nevada (149)
New Hampshire (75)
New Jersey (3429)
New Mexico (19)
New York (3598)
North Carolina (1777)
North Dakota (10)
Northern California (7585)
Ohio (371)
Oklahoma (15)
Oregon (36)
Pennsylvania (2828)
Puerto Rico (28)
Rhode Island (40)
South America (528)
South Carolina (83)
South Dakota (1)
Southern California (5859)
Tennessee (157)
Texas (2387)
United States (49537)
Utah (430)
Vermont (1)
Virginia (268)
Washington D.C. (52)
Washington State (1176)
West Virginia (2)
Wisconsin (123)
Wyoming (2)
586,172 Results for "onconova therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
Onconova Therapeutics, Inc. today announced that the Company will present an abstract related to preclinical studies conducted by the Company and its collaborators to further characterize the mechanism of rigosertib at the American Association for Cancer Research Annual Meeting.
March 8, 2024
·
5 min read
BioCapital
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
Onconova Therapeutics, Inc., and Trawsfynydd Therapeutics, Inc., a privately-held biotechnology company developing next-generation, best-in-class antivirals for influenza, COVID and other infectious diseases, announced that the companies have entered into a definitive merger agreement to combine in an all-stock transaction.
April 2, 2024
·
13 min read
Press Releases
Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
October 13, 2026
·
4 min read
Pharm Country
Onconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCL
Onconova Therapeutics, Inc. announced that Onconova and collaborators will present a preclinical poster related to its lead program, narazaciclib, at the 65th American Society for Hematology Annual Meeting & Exposition, taking place in San Diego, California from December 9 to 12, 2023.
November 2, 2023
·
5 min read
Business
Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today reported third quarter 2023 financial results and provided an update on recent pipeline progress.
November 14, 2023
·
9 min read
Pharm Country
Onconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
Onconova Therapeutics, Inc. today announced preclinical data, highlighting narazaciclib’s preclinical activity in Bruton’s kinase inhibitor (BTKi)-resistant mantle cell lymphoma (MCL).
December 12, 2023
·
7 min read
Business
Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results
Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today reported second quarter 2023 financial results and provided an update on recent pipeline progress.
August 10, 2023
·
8 min read
Press Releases
Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference
October 13, 2026
·
2 min read
Press Releases
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
September 23, 2026
·
3 min read
Pharm Country
Onconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium
Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”) today announced an upcoming presentation at the International Society of Investigative Dermatology (ISID) International Epidermolysis Bullosa Symposium, which is being held in Osaka, Japan through May 9, 2023.
May 8, 2023
·
5 min read
1 of 58,618
Next
